in vivo Variation in Metabotropic Glutamate Receptor Subtype 5 Binding Using Positron Emission Tomography and [11C]ABP688

Imaging Changes in Glutamate Transmission In Vivo with the Metabotropic Glutamate Receptor 5 Tracer [11C] ABP688 and N-Acetylcysteine Challenge

(2011) Nobumi Miyake et al.   BIOLOGICAL PSYCHIATRY

In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons

(2011) Christine DeLorenzo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion

(2009) Christopher Barkus et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Modeling Considerations for In Vivo Quantification of the Dopamine Transporter using [11C]PE2I and Positron Emission Tomography

(2009) Christine DeLorenzo et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes

(2009) J Elia et al.   MOLECULAR PSYCHIATRY

Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration

(2009) Arno Klein et al.   NEUROIMAGE

Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers

(2009) Ningning Guo et al.   NEUROPSYCHOPHARMACOLOGY

Region-specific alteration in brain glutamate: Possible relationship to risk-taking behavior

(2009) Bernadette M. Cortese et al.   PHYSIOLOGY & BEHAVIOR

Measurement of Striatal and Extrastriatal Dopamine Transporter Binding with High-Resolution PET and [11C]PE2I: Quantitative Modeling and Test—Retest Reproducibility

(2008) Jussi Hirvonen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Modeling Considerations for 11C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET

(2008) M. S. Milak et al.   JOURNAL OF NUCLEAR MEDICINE

ADX47273 [S-(4-Fluoro-phenyl)- -methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

(2008) F. Liu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome

(2008) Gül Dölen et al.   JOURNAL OF PHYSIOLOGY-LONDON

Accruing Preclinical Evidence about Metabotropic Glutamate 5 Receptor Antagonists as Treatments for Drug Dependence Highlights the Irreplaceable Contributions of Animal Studies to the Discovery of New Medications for Human Disorders

(2008) Athina Markou   NEUROPSYCHOPHARMACOLOGY

mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats

(2008) Justin T Gass et al.   NEUROPSYCHOPHARMACOLOGY

Mood disorders: Regulation by metabotropic glutamate receptors

(2007) Andrzej Pilc et al.   BIOCHEMICAL PHARMACOLOGY